| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 08.08.2018 og
angivet som gældende fra 08.08.2018 (2091
dage). |
Ingen historik.
| Branche | | Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900). |
| Sidst opdateret den 10.05.2022 og
angivet som gældende fra 01.01.2022 (849
dage). |
| Historik | Start | Stop |
|---|
| Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900) | 01.01.2022 | |
| Fremstilling af andet elektrisk udstyr (279000) | 08.08.2018 | 31.12.2021 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 01.09.2020 og
angivet som gældende fra 01.09.2020 (1336
dage). |
| Historik | Start | Stop |
|---|
| false | 01.09.2020 | |
| true | 08.08.2018 | 31.08.2020 |
| Revisor | | KPMG P/S |
| Sidst opdateret den 01.09.2020 og
angivet som gældende fra 01.09.2020 (1336
dage). |
Ingen historik.
| Kontaktoplysninger | | msc@optoceutics.com. |
| Sidst opdateret den 29.04.2022 og
angivet som gældende fra 29.04.2022 (731
dage). |
| Historik | Start | Stop |
|---|
| msc@optoceutics.com | 29.04.2022 | |
| mschultzcarstensen@gmail.com | 08.08.2018 | 28.04.2022 |
| Telefonnummer | | 23456442. |
| Sidst opdateret den 08.08.2018 og
angivet som gældende fra 08.08.2018 (2091
dage). |
Ingen historik.
| Navne | | Optoceutics ApS. |
| Sidst opdateret den 26.11.2018 og
angivet som gældende fra 08.11.2018 (1999
dage). |
| Historik | Start | Stop |
|---|
| Optoceutics ApS | 08.11.2018 | |
| Optoceutics IVS | 08.08.2018 | 07.11.2018 |
| Binavne | | Optoceutical ApS. |
| Sidst opdateret den 28.11.2018 og
angivet som gældende fra 28.11.2018 (1979
dage). |
| Historik | Start | Stop |
|---|
| Optoceutical ApS | 28.11.2018 | |
| Optoceutics ApS | 26.11.2018 | 27.11.2018 |
| Optoceutical IVS | 08.08.2018 | 25.11.2018 |
| Tegningsregel | | Selskabet tegnes af en direktør i forening med
bestyrelsens formand, af tre medlemmer af bestyrelsen i forening, eller af den
samlede bestyrelse. |
| Sidst opdateret den 19.03.2019 og
angivet som gældende fra 19.03.2019 (1868
dage). |
| Fortolkning
(3 tegningsmuligheder)
| | 1 direktør + formanden |
| 3 bestyrelsesmedlemmer + |
| bestyrelsen |
| Historik | Start | Stop |
|---|
| Selskabet tegnes af en direktør i forening med
bestyrelsens formand, af tre medlemmer af bestyrelsen i forening, eller af den
samlede bestyrelse | 19.03.2019 | |
| Virksomheden tegnes af en direktør alene | 08.08.2018 | 18.03.2019 |
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:KPMG
Revisionsvirksomhedens CVR-nr.:25578198
Virksomhedens regnskabsklasse:Reporting class B
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of Optoceutics ApS for the financial year 1 January - 31 December 2022, comprising income statement, balance sheet, statement of changes in equity and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2022 and of the results of the Company's operations for the financial year 1 January - 31 December 2022 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the Management's reviewManagement is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Hjemmeside | | www.optoceutics.com. |
| Sidst opdateret den 08.08.2018 og
angivet som gældende fra 08.08.2018 (2091
dage). |
Ingen historik.
LoginOpret gratis brugere-conomic integration